Trevor Hamilton

Dr. Trevor Hamilton


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Surgery
Verified
Journal Article
Closed access
CHCaroline Huynh
Caroline Huynh
SMStephanie Minkova
Stephanie Minkova
DKDiane Kim
Diane Kim
HSHeather Stuart
Heather Stuart
THTrevor Hamilton
Trevor Hamilton

21 February 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
TKTaylor Kandler
Taylor Kandler
ECEliane Cortez
Eliane Cortez
LCLani Clinton
Lani Clinton
AHAmanda Hemmerich
Amanda Hemmerich
Osama AhmedOsama Ahmed
Osama Ahmed
XFXiaolan Feng
Xiaolan Feng
Malignant gastrointestinal neuroectodermal tumor (GNET) is an ultra-rare soft tissue sarcoma, therefore often misdiagnosed and has no available standard treatment. Here, we report 3 cases of metastatic GNET with variable clinical courses. Our small case series as well as extensive literature review, further support that GNET is a spectrum of diseases with variable inherent biology and prognosis. Surgical management in the setting of recurrent/metastatic disease may be appropriate for GNET with indolent nature. Response to systemic treatments including chemotherapy and targeted treatments is variable, likely related to heterogenous biology as well. Furthermore, we retrospectively identified 20 additional GNET cases from Foundation Medicine’s genomic database and expanded on their clinicopathological and genomic features. Comprehensive genomic profiling (CGP) with DNA and RNA sequencing of this cohort, in the course of clinical care, demonstrated recurrent EWSR1 chromosomal rearrangements and a sparsity of additional recurrent or driver genomic alterations. All cases had low tumor mutational burden (TMB) and were microsatellite stable.

11 March 2023 in The American Journal of Surgery
Verified
Journal Article
Closed access
JLJessica J. Lie
Jessica J. Lie
KNKylie Nabata
Kylie Nabata
JZJenny W. Zhang
Jenny W. Zhang
DZDarren Zhao
Darren Zhao
CPChan Mi Park
Chan Mi Park
THTrevor Hamilton
Trevor Hamilton

28 January 2019 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
THTrevor Hamilton
Trevor Hamilton
AMAndrea J. MacNeill
Andrea J. MacNeill
HLHoward Lim
Howard Lim
MHM. G. Myriam Hunink
M. G. Myriam Hunink

19 February 2025 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JLJessica J. Lie
Jessica J. Lie
KNKylie Nabata
Kylie Nabata
JZJenny W. Zhang
Jenny W. Zhang
SRSabrina Rai
Sabrina Rai
DZDarren Zhao
Darren Zhao
THTrevor Hamilton
Trevor Hamilton

1 December 2020 in Current Oncology
Verified
Journal Article
Open access
PDF file
FSFarhana Shariff
Farhana Shariff
DBDanielle Bischof
Danielle Bischof
AGAnand Govindarajan
Anand Govindarajan
RPRebecca Prince
Rebecca Prince
RBRonald Burkes
Ronald Burkes
AMAndrea McCart
Andrea McCart
Background: The COVID-19 pandemic has put enormous pressure on hospital resources, and has affected all aspects of patient care. As operative volumes decrease, cancer surgeries must be triaged and prioritized with careful thought and attention to ensure maximal benefit for the maximum number of patients. Peritoneal malignancies present a unique challenge, as surgical management can be resource intensive, but patients have limited non-surgical treatment options. This review summarizes current data on outcomes and resource utilization to help inform decision-making and case prioritization in times of constrained health care resources. Methods: A rapid literature review was performed, examining surgical and non-surgical outcomes data for peritoneal malignancies. Narrative data synthesis was cross-referenced with relevant societal guidelines. Peritoneal malignancy surgeons and medical oncologists reviewed recommendations to establish a national perspective on case triage and mitigating treatment strategies. Results and Conclusions: Triage of peritoneal malignancies during this time of restricted health care resource is nuanced and requires multidisciplinary discussion with consideration of individual patient factors. Prioritization should be given to patients where delay may compromise resectability of disease, and where alternative treatment options are lacking. Mitigating strategies such as systemic chemotherapy and/or surgical deferral may be utilized with close surveillance for disease stability or progression, which may affect surgical urgency. Unique hospital capacity, and ability to manage the complex post-operative course for these patients must also be considered to ensure patient and system needs are aligned.